Rivastigmine has been evaluated in the treatment of subjects with mild to moderate AD.
Rivastigmine may increase the acid in your stomach.
Rivastigmine is a type of medicine called an acetylcholinesterase inhibitor.
Do not stop taking it unless your doctor instructs you to do so. It represents the assessment of a skilled clinician using validated scales based on his her observation at interviews conducted separately with the patient and the caregiver familiar with the behavior of the patient over the interval rated.
Consistent with these observations is the finding that no drug interactions related to cytochrome P450 have been observed in humans.
Bond M, Rogers G, Peters J, Anderson R, Hoyle M, Miners A, Moxham T, Davis S, Thokala P, Wailoo A, Jeffreys M, Hyde C. Discontinuation should be considered when evidence of a therapeutic effect is no longer present. Patients with Alzheimer s disease may lose weight.
Rivastigmine in apathetic but dementia and depression-free patients with Parkinson s disease a double-blind, placebo-controlled, randomised clinical trial.
Ask your doctor before use if you are taking the following medications:
This would put you at higher risk for side effects.
According to the prescribing information for Cymbalta, these side effects can occur in up to five percent of people taking the drug.
History of application site reaction with transdermal patch. Kretzschmar, Sigrid Poser, Claudia Trenkwalder, Markus Otto. Medicines and their possible side effects can affect individual people in different ways.